Clinical Trials Browser

Phase 1/2 × Immunotherapy, Adoptive × Breast × Clear all

NCT04609215 2022-04-20

ImmunoBreast - A Phase Ib Study

Phase 1/2 Unknown

Breast Neoplasms, Triple Negative Breast Neoplasms